Osilodrostat, a potent oral 11β-hydroxylase inhibitor:...

Pituitary 2016 / 4 Vol. 19; Iss. 2

Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

Fleseriu, Maria, Pivonello, Rosario, Young, Jacques, Hamrahian, Amir H., Molitch, Mark E., Shimizu, Chikara, Tanaka, Tomoaki, Shimatsu, Akira, White, Tracy, Hilliard, Annie, Tian, Chuan, Sauter, Nicho
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Pituitary
DOI:
10.1007/s11102-015-0692-z
Date:
April, 2016
File:
PDF, 918 KB
english, 2016
Conversion to is in progress
Conversion to is failed